Madrigal Drug Patent Portfolio
Madrigal owns 1 orange book drug protected by 5 US patents Given below is the list of Madrigal's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10376517 | Methods of synthesizing thyroid hormone analogs and polymorphs thereof | 17 Sep, 2033 | Active |
| US11564926 | Methods of synthesizing thyroid hormone analogs and polymorphs thereof | 17 Sep, 2033 | Active |
| US11986481 | Method of synthesizing thyroid hormone analogs and polymorphs thereof | 17 Sep, 2033 | Active |
| US9266861 | Method of synthesizing thyroid hormone analogs and polymorphs thereof | 17 Sep, 2033 | Active |
| US7452882 | Thyroid hormone analogs | 12 Sep, 2026 | Active |
Latest Legal Activities on Madrigal's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Madrigal.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 26 Jun, 2024 | US7452882 |
|
Email Notification
Critical
| 26 Jun, 2024 | US7452882 |
| Initial letter Re: PTE Application to regulating agency | 07 May, 2024 | US9266861 |
| Initial letter Re: PTE Application to regulating agency | 07 May, 2024 | US7452882 |
| Requirement for information sent under 37 CFR 1.750 | 07 May, 2024 | US7452882 |
| Patent Term Extension Application under 35 USC 156 Filed | 02 May, 2024 | US7452882 |
| Patent Term Extension Application under 35 USC 156 Filed | 02 May, 2024 | US9266861 |
|
Email Notification
Critical
| 17 Apr, 2024 | US7452882 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 17 Apr, 2024 | US7452882 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 11 Apr, 2024 | US9266861 |
|
Email Notification
Critical
| 11 Apr, 2024 | US9266861 |
| 7.5 yr surcharge - late pmt w/in 6 mo, Large Entity | 29 Aug, 2023 | US9266861 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 29 Aug, 2023 | US9266861 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 13 Feb, 2023 | US10376517 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 31 Jan, 2023 | US11564926 |
Madrigal's Family Patents
Madrigal Drug List
Given below is the complete list of Madrigal's drugs and the patents protecting them.
1. Rezdiffra
Rezdiffra is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10376517 | Methods of synthesizing thyroid hormone analogs and polymorphs thereof |
17 Sep, 2033
(8 years from now)
| Active |
| US11564926 | Methods of synthesizing thyroid hormone analogs and polymorphs thereof |
17 Sep, 2033
(8 years from now)
| Active |
| US11986481 | Method of synthesizing thyroid hormone analogs and polymorphs thereof |
17 Sep, 2033
(8 years from now)
| Active |
| US9266861 | Method of synthesizing thyroid hormone analogs and polymorphs thereof |
17 Sep, 2033
(8 years from now)
| Active |
| US7452882 | Thyroid hormone analogs |
12 Sep, 2026
(1 year, 10 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rezdiffra's drug page